239 related articles for article (PubMed ID: 16732330)
21. Isolation and characterization of cytoplasmic cyclin D1 mutants.
Murakami H; Horihata M; Andojo S; Yoneda-Kato N; Kato JY
FEBS Lett; 2009 May; 583(10):1575-80. PubMed ID: 19409388
[TBL] [Abstract][Full Text] [Related]
22. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.
Nakagawa H; Wang TC; Zukerberg L; Odze R; Togawa K; May GH; Wilson J; Rustgi AK
Oncogene; 1997 Mar; 14(10):1185-90. PubMed ID: 9121767
[TBL] [Abstract][Full Text] [Related]
23. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
Diehl JA; Cheng M; Roussel MF; Sherr CJ
Genes Dev; 1998 Nov; 12(22):3499-511. PubMed ID: 9832503
[TBL] [Abstract][Full Text] [Related]
24. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
Skomedal H; Kristensen GB; Nesland JM; Børresen-Dale AL; Tropé C; Holm R
J Pathol; 1999 Apr; 187(5):556-62. PubMed ID: 10398121
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression.
Lee Y; Dominy JE; Choi YJ; Jurczak M; Tolliday N; Camporez JP; Chim H; Lim JH; Ruan HB; Yang X; Vazquez F; Sicinski P; Shulman GI; Puigserver P
Nature; 2014 Jun; 510(7506):547-51. PubMed ID: 24870244
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition.
Susaki E; Nakayama K; Nakayama KI
Mol Cell Biol; 2007 Jul; 27(13):4626-40. PubMed ID: 17452458
[TBL] [Abstract][Full Text] [Related]
27. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
28. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
[TBL] [Abstract][Full Text] [Related]
29. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
[TBL] [Abstract][Full Text] [Related]
30. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells.
Zhou P; Jiang W; Zhang YJ; Kahn SM; Schieren I; Santella RM; Weinstein IB
Oncogene; 1995 Aug; 11(3):571-80. PubMed ID: 7630641
[TBL] [Abstract][Full Text] [Related]
31. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis.
Farago M; Dominguez I; Landesman-Bollag E; Xu X; Rosner A; Cardiff RD; Seldin DC
Cancer Res; 2005 Jul; 65(13):5792-801. PubMed ID: 15994955
[TBL] [Abstract][Full Text] [Related]
32. Mutations associated with familial melanoma impair p16INK4 function.
Ranade K; Hussussian CJ; Sikorski RS; Varmus HE; Goldstein AM; Tucker MA; Serrano M; Hannon GJ; Beach D; Dracopoli NC
Nat Genet; 1995 May; 10(1):114-6. PubMed ID: 7647780
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
Chen B; Pollard JW
Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329
[TBL] [Abstract][Full Text] [Related]
34. PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
Yang Y; Wu J; Cai J; He Z; Yuan J; Zhu X; Li Y; Li M; Guan H
Int J Cancer; 2015 Feb; 136(4):E39-50. PubMed ID: 25142862
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity.
Lilischkis R; Sarcevic B; Kennedy C; Warlters A; Sutherland RL
Int J Cancer; 1996 Apr; 66(2):249-54. PubMed ID: 8603820
[TBL] [Abstract][Full Text] [Related]
36. Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase.
Aggarwal P; Vaites LP; Kim JK; Mellert H; Gurung B; Nakagawa H; Herlyn M; Hua X; Rustgi AK; McMahon SB; Diehl JA
Cancer Cell; 2010 Oct; 18(4):329-40. PubMed ID: 20951943
[TBL] [Abstract][Full Text] [Related]
37. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
Musgrove EA; Lee CS; Cornish AL; Swarbrick A; Sutherland RL
Mol Endocrinol; 1997 Jan; 11(1):54-66. PubMed ID: 8994188
[TBL] [Abstract][Full Text] [Related]
38. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression.
Shimura T; Kakuda S; Ochiai Y; Nakagawa H; Kuwahara Y; Takai Y; Kobayashi J; Komatsu K; Fukumoto M
Oncogene; 2010 Aug; 29(34):4826-37. PubMed ID: 20562919
[TBL] [Abstract][Full Text] [Related]
39. Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis.
Lin DI; Lessie MD; Gladden AB; Bassing CH; Wagner KU; Diehl JA
Oncogene; 2008 Feb; 27(9):1231-42. PubMed ID: 17724472
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
Scimè A; Li L; Ciavarra G; Whyte P
J Cell Physiol; 2008 Mar; 214(3):568-81. PubMed ID: 17894419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]